Sunt Covi-XIX vaccina dignitas questus, si tu non C percent efficax?

Wang Huaqing, dux periti de immunization progressio ad Seres Centrum pro morbo imperium et ne, dixit ad Vaccinum non solum probatus, si eius efficaciam occurrit quaedam signa.

Sed ita ut in Vaccinum efficaciora esse ponere eius altum coverage rate et consolidant.

Sub tali fortuna, morbus potest efficaciter regi.

"Vaccination est multo melius via ut ne morbus, ut prohibere eius propagationem, aut ad redigendum eius pestilentia intensionem.

Nunc habemus ad Covi XIX vaccine.

Nos coepi inoculation in key areas et clavis populationibus, intendentes ad statuam immune claustra in population per ordinem inoculation, ut ad redigendum transitum intensionem ad virum, et tandem consequi ad propositum et stetit ad pestes et tandem ad propositum.

If everyone think now of the vaccine is not one hundred percent, I don't getting a vaccination, it can't build up our immune barrier, also can't build up immunity, once there is the source of infection, because the vast majority have no immunity, the disease occurs in popularity, are also likely to be spread.

In facto, in pestilentia et propagationem de cessum mensurarum ad imperium illud, sumptus est valde magna.

But with the vaccine, we give it early, people are immunized, and the more we give it, the more immune barrier is built up, and even if there are scattered outbreaks of the virus, it doesn't become a pandemic, and it stops the spread of the disease as much as we would like.”Wang Huaqing said.

Mr Wang said, for example, such as measles, pertussis is strong two infectious diseases, but through vaccination, by very high coverage, and consolidate such high coverage, has made these two diseases is well controlled, the measles incidence of less than 1000 last year, reached the lowest level in history, pertussis has fallen to a low level, All of this is due to the fact that through vaccination, with high coverage, the immune Obice in population secured.

Nuper, in Ministerio Salutem de Chile Published a realis mundi studium in tutela effectum de Sinovac coronavirus vaccine, quae ostendit a Praecaventur Donec Rate of LXVII% et mortalitatis rate of LXXX%.